Tang-du Hospital
Clinical trials sponsored by Tang-du Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Brain aneurysm repair: Stent-Assisted coiling put to the test Results expected Oct 2026 (estimated)
- Can a heart drug stop pneumonia after a stroke? Results expected Oct 2026 (estimated)
- Promising cocktail aims to shrink tonsil tumors before surgery Results expected Nov 2026 (estimated)
- Could a special formula prevent gut trouble after brain injury? Results expected Nov 2026 (estimated)
- Gut-Brain connection in IBS: scientists hunt for clues to anxiety and depression Results expected Dec 2026 (estimated)
-
Can a targeted pill plus chemo shrink lung tumors before surgery?
Disease control OngoingThis phase 2 trial is testing whether giving the targeted drug furmonertinib along with standard chemotherapy before surgery can shrink tumors in people with a specific type of lung cancer (EGFR-mutated, stage II to IIIB). Participants take furmonertinib daily for 9 weeks plus th…
Phase 2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Stool test may predict gut healing in ulcerative colitis
Knowledge-focused By invitation onlyThis study is testing whether a simple stool test can predict if the gut lining is healing in people with moderate-to-severe ulcerative colitis who are starting biologic therapy for the first time. Researchers will measure levels of a protein called calprotectin in stool samples …
Sponsor: Tang-Du Hospital • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC